Securities Code: 300246
Bond Code: 123065
Securities Abbreviation: Baolight
Bond Abbreviation: Baolight Convertible Bond
Announcement Number: 2026-057
Guangdong Baolight Medical Technology Co., Ltd.
Announcement on Termination of Control Right Change Plan, Resumption of Trading and Resumption of Share Conversion
The Company and the Board of Directors guarantee the authenticity, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or major omissions.
Special Reminder:
-
The stock (Securities Abbreviation: Baolight, Securities Code: 300246) and convertible corporate bonds (Bond Abbreviation: Baolight Convertible Bond, Bond Code: 123065) of Guangdong Baolight Medical Technology Co., Ltd. (hereinafter referred to as the "Company") will resume trading on August 10, 2026 (Monday) at the opening. The Company's convertible corporate bonds "Baolight Convertible Bond" will resume share conversion.
-
Time for resumption of convertible bond share conversion: August 10, 2026
-
The termination of the control right change plan will not adversely affect the Company's production and operation, nor will it affect the Company's future development strategy. We kindly remind investors to invest rationally and pay attention to investment risks.